Man-Fung Yuen Selected Research

Man-Fung Yuen Research Topics

Disease

160	Chronic Hepatitis B 05/2024 - 02/2002
71	Infections 05/2024 - 02/2002
65	Fibrosis (Cirrhosis) 05/2024 - 03/2002
62	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 03/2002
62	Hepatitis B 11/2023 - 01/2003
17	Neoplasms (Cancer) 12/2023 - 09/2002
16	Liver Cirrhosis (Hepatic Cirrhosis) 12/2022 - 12/2003
13	Hepatitis 09/2023 - 02/2002
11	Disease Progression 01/2023 - 08/2004
9	Liver Neoplasms (Liver Cancer) 10/2023 - 12/2003
9	Liver Diseases (Liver Disease) 01/2023 - 08/2004
8	Chronic Hepatitis C 01/2022 - 02/2002
7	Non-alcoholic Fatty Liver Disease 09/2023 - 07/2014
7	Viremia 01/2022 - 02/2002
6	Carcinogenesis 12/2023 - 05/2003
6	Fatty Liver 10/2023 - 01/2020
4	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023 - 01/2018
3	Hypertension (High Blood Pressure) 10/2023 - 01/2022
3	Persistent Infection 01/2021 - 09/2008
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2021 - 01/2006
3	Neoplasm Metastasis (Metastasis) 11/2020 - 09/2002
3	Cholangitis 01/2020 - 07/2002
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 06/2017
3	Sepsis (Septicemia) 07/2019 - 10/2014
3	Stomach Neoplasms (Stomach Cancer) 10/2012 - 05/2003
2	Hepatitis C 10/2023 - 05/2018
2	Hepatitis E 01/2023 - 06/2004
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 11/2014
2	Fever (Fevers) 11/2022 - 01/2020
2	Diabetes Mellitus 01/2020 - 01/2019
2	Acute-On-Chronic Liver Failure 11/2019 - 07/2015
2	Substance-Related Disorders (Drug Abuse) 01/2018 - 09/2010
2	Coinfection 06/2017 - 01/2011
2	Inflammation (Inflammations) 01/2017 - 08/2013

Drug/Important Bio-Agent (IBA)

74	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2024 - 06/2004
69	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 07/2002
66	Antiviral Agents (Antivirals)IBA 05/2024 - 03/2003
53	Hepatitis B e AntigensIBA 04/2024 - 11/2002
29	entecavir FDA Link 03/2024 - 01/2006
26	AntigensIBA 11/2023 - 06/2004
23	NucleosidesIBA 10/2023 - 12/2003
21	NucleotidesIBA 10/2023 - 11/2004
20	Lamivudine (Epivir)FDA Link 10/2017 - 07/2002
19	InterferonsIBA 01/2023 - 04/2003
18	Alanine Transaminase (SGPT)IBA 10/2023 - 11/2004
16	Biomarkers (Surrogate Marker)IBA 08/2023 - 12/2008
13	nasIBA 04/2024 - 01/2007
12	Tenofovir (Viread)FDA Link 05/2024 - 01/2011
12	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2012
10	RNA (Ribonucleic Acid)IBA 12/2023 - 02/2019
9	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 03/2002
8	Ribavirin (Virazole)FDA LinkGeneric 10/2023 - 04/2003
8	BilirubinIBA 12/2021 - 03/2002
7	Telbivudine FDA Link 12/2019 - 09/2004
6	Circular DNAIBA 01/2022 - 10/2006
6	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 10/2011
5	AlbuminsIBA 10/2023 - 08/2003
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023 - 09/2002
5	adefovirIBA 12/2019 - 01/2009
4	CateninsIBA 12/2023 - 05/2003
4	Cadherins (E-Cadherin)IBA 12/2023 - 05/2003
4	Transaminases (Aminotransferases)IBA 01/2023 - 01/2006
4	Messenger RNA (mRNA)IBA 01/2022 - 10/2006
4	HLA-DP Antigens (HLA-DP)IBA 03/2014 - 01/2013
3	SodiumIBA 11/2023 - 11/2019
3	HDL CholesterolIBA 09/2023 - 01/2021
3	Viral ProteinsIBA 01/2023 - 11/2019
3	JNJ-56136379IBA 01/2023 - 01/2022
3	Reverse Transcriptase InhibitorsIBA 11/2022 - 09/2015
3	VaccinesIBA 12/2021 - 12/2008
3	Viral DNAIBA 01/2021 - 01/2017
3	BerberineIBA 08/2020 - 12/2015
3	((1- ((2- amino- 9H- purin- 9- yl)methyl)cyclopropyl)oxy)methylphosphonic acid dipivoxylIBA 01/2018 - 06/2014
3	hepatitis B hyperimmune globulinIBA 12/2015 - 06/2013
3	Interferon-alpha (Interferon Alfa)IBA 01/2013 - 06/2003
3	adefovir dipivoxil (Hepsera)FDA Link 01/2007 - 12/2003
2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2023
2	Nucleic AcidsIBA 11/2023 - 01/2021
2	TransferasesIBA 10/2023 - 01/2022
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2023 - 05/2018
2	LDL CholesterolIBA 09/2023 - 07/2014
2	ProdrugsIBA 01/2023 - 05/2009
2	Toll-Like Receptor 7IBA 01/2023 - 01/2021
2	pgRNAIBA 01/2023 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2023 - 11/2022
2	ARC-520IBA 01/2022 - 01/2020
2	Amino Acids FDA Link 01/2021 - 09/2016
2	Carrier Proteins (Binding Protein)IBA 03/2019 - 07/2017
2	Surface Antigens (Surface Antigen)IBA 01/2018 - 01/2012
2	huanglianIBA 12/2015 - 01/2011

Therapy/Procedure

95	Therapeutics 04/2024 - 02/2002
21	Liver Transplantation 09/2023 - 01/2003
7	Duration of Therapy 04/2024 - 08/2008
4	Aftercare (After-Treatment) 04/2024 - 01/2011
3	Retreatment 08/2023 - 01/2023
3	Drug Therapy (Chemotherapy) 01/2023 - 11/2014
3	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2019 - 02/2002
2	Glycemic Control 11/2023 - 01/2023
2	RNAi Therapeutics 11/2023 - 10/2023
2	Withholding Treatment 01/2021 - 04/2015